Be sure to check our sister interview main ratings news website

Collagen Solutions CEO Stewart White Interview on Final Results

Collagen Solutions Plc LON:COS CEO Stewart White discusses the release of it’s Final Results for Year End Mar 31 2015.

 

 

Dr Stewart White was CEO of Collbio and has recent and direct board experience of an AIM quoted company. Stewart has international experience in operations, business and product development, and ‘Good Manufacturing Practices’ (GMP) compliant manufacturing of collagen medical devices, advanced biologics and Active Pharmaceutical Ingredients in both Small to Medium Enterprises as well as global pharmaceutical companies. Stewart is a graduate of the University of Strathclyde and holds a First Class degree in Applied Microbiology, a Ph.D. in Fermentation Technology and Bioprocessing and an MBA.

 

Collagen Solutions Plc is a global provider of medical grade collagen formulations and components for use in regenerative medicine, medical devices and in-vitro diagnostics.

Read in Full
Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    X
    LinkedIn
    DirectorsTalk

    More articles like this

    Hardman & Co

    Collagen Solutions Targeting long-term sustainable growth

    19th December 2017

    Collagen Solutions Plc (LON:COS) is a biomaterials company developing and manufacturing medical grade collagen components for use in medical devices, research, and regenerative medicine. A number of investment initiatives have been introduced to accelerate the rate

    Hardman & Co

    Collagen Solutions Engineering towards CE Mark

    21st September 2017

    Collagen Solutions Plc (LON:COS) is a biomaterials company developing and manufacturing medical grade collagen components for use in medical devices, research, and regenerative medicine. A number of investment initiatives have been introduced recently to accelerate the

    Hardman & Co

    Collagen Solutions Plc Engineering cartilage repairs

    13th March 2017

    Collagen Solutions Plc (LON:COS) is a biomaterials company developing and manufacturing medical grade collagen components for use in medical devices, research, and regenerative medicine. A number of investment initiatives have been introduced over the last year

    Hardman & Co

    Collagen Solutions Plc Focus on R&D

    29th September 2016

    Collagen Solutions Plc (LON:COS) is a biomaterials company developing and manufacturing medical grade collagen components for use in medical devices, in vitro diagnostics, and regenerative medicine. The strategic plan is to invest into its own pipeline

    Hardman & Co

    Collagen Solutions Plc Secure base, and opportunities intact

    16th February 2016

    Collagen Solutions Plc (LON:COS) is a biomaterials company developing and manufacturing medical grade collagen components for use in medical devices, regenerative medicine, and in vitro diagnostic products. It aims to grow organically and through acquisition to

    DirectorsTalk

    Panmure Gordon thoughts on Collagen Solutions this morning

    13th July 2015

    Panmure Gordon Analyst Dr Mike Mitchell said this morning on Collagen Solutions: “Prelim results have delivered a performance in-line with our expectations. The company reports revenue and other income of £1.04m (PGe £1.0m, 2014: £0.02m) and

    DirectorsTalk

    Collagen Solutions plc final results with increased revenue

    13th July 2015

    Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics, has given DirectorsTalk its final results for the year ended 31 March

    © 2024 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.